We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Adult Stem Cells Restore Function after Stroke

By Biotechdaily staff writers
Posted on 21 May 2002
A study has demonstrated the ability of transplanted adult stem cells to restore function in laboratory rats after a stroke. More...
Conducted by researchers at the University of Minnesota department of neurosurgery and Stem Cell Institute (Minneapolis, USA), the study was reported in the March 2002 issue of Experimental Neurology.

The stem cells were isolated and expanded from human bone marrow and transplanted into rats seven days after an ischemic stroke injury to the brain. Before the transplant, the rats could not properly use their forelimbs and hind limbs. Weeks after the transplant, they regained use of their limbs. The researchers found that the transplanted cells developed into cells that showed the characteristics of neurons, astrocytes, and oligodendroglia, the major types of cells in the brain. These results suggest that stem cells obtained from bone marrow may be used as a source of cells to repair the brain and restore function in human patients who have had a stroke.

"Can stem cells be transplanted one, two, six, or 12 months after a stroke and still restore function? Another important question that still needs to be addressed for this research is whether bone marrow stem cells maintain a stable neural phenotype over prolonged periods after transplantation,” said Walter Low, Ph.D., a professor of neurosurgery and principal investigator for the study.






Related Links:
Univ. of Minnesota

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.